Evidence map›Paper›PMID 28471360›Full record

ArticleActa crystallographica. Section F, Structural biology communications2017

Transcription factor Rv0081 from Mycobacterium tuberculosis: purification, crystallization and initial crystallographic analysis.

Shishang Dong, Zhenzhen Ding, Yu Wang, Yan Yang, Yonghong Mao, Ying Wang

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shishang DongCollege of Life Sciences, Nankai University, Tianjin 300071, People's Republic of China.
Zhenzhen DingTianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, People's Republic of China.
Yu WangTianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, People's Republic of China.
Yan YangTianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, People's Republic of China.
Yonghong MaoTianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, People's Republic of China.
Ying WangTianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, People's Republic of China.

Funding

Ministry of Science and Technology of China `973' Project 2013CB911103Ministry of Science and Technology of China `973' Project 2014CB542800National Natural Science Foundation of China 31670731Tianjin Municipal Natural Science Foundation 13ZCZDSY04200Tianjin Municipal Natural Science Foundation 14JCQNJC10100Tianjin Municipal Natural Science Foundation 14ZCZDSY00039
6 · The paper itself

Abstract

Because of its high infectivity and pathogenicity, Mycobacterium tuberculosis is a serious threat to human health. While the transcription-regulatory system of M. tuberculosis remains incompletely understood, Rv0081, an essential regulatory hub, is known to mediate the initial response to hypoxia in the long-term survival of M. tuberculosis. Here, the production, crystallization and initial X-ray crystallographic analysis of Rv0081 are reported. The crystals of Rv0081 belonged to space group P6

Indexed as

Amino Acid SequenceBacterial ProteinsCloning, MolecularCrystallizationCrystallography, X-RayEscherichia coliGene ExpressionGenetic VectorsMycobacterium tuberculosisRecombinant ProteinsTranscription FactorsX-Ray DiffractionBacterial ProteinsRecombinant ProteinsTranscription FactorsMycobacterium tuberculosisRv0081transcription factor

Identifiers

PMID28471360
PMCPMC5417318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.